These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Value of renal biopsy in the prognosis of liver transplantation in familial amyloid polyneuropathy ATTR Val30Met patients. Oguchi K; Takei Y; Ikeda S Amyloid; 2006 Jun; 13(2):99-107. PubMed ID: 16911964 [TBL] [Abstract][Full Text] [Related]
6. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy. Hattori T; Takei Y; Koyama J; Nakazato M; Ikeda S Amyloid; 2003 Dec; 10(4):229-39. PubMed ID: 14986482 [TBL] [Abstract][Full Text] [Related]
7. Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy. Ebenezer GJ; Liu Y; Judge DP; Cunningham K; Truelove S; Carter ND; Sebastian B; Byrnes K; Polydefkis M Ann Neurol; 2017 Jul; 82(1):44-56. PubMed ID: 28598015 [TBL] [Abstract][Full Text] [Related]
8. Familial amyloid polyneuropathy type I (Portuguese): distribution and characterization of renal amyloid deposits. Lobato L; Beirão I; Guimarães SM; Droz D; Guimarães S; Grünfeld JP; Noël LH Am J Kidney Dis; 1998 Jun; 31(6):940-6. PubMed ID: 9631837 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of familial amyloid polyneuropathy]. Adams D; Samuel D; Slama M Presse Med; 2012 Sep; 41(9 Pt 1):793-806. PubMed ID: 22341949 [TBL] [Abstract][Full Text] [Related]
10. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan. Miyake Z; Nakamagoe K; Ezawa N; Yoshinaga T; Hashimoto R; Sato T; Sekijima Y; Tamaoka A Intern Med; 2019 Mar; 58(5):713-718. PubMed ID: 30333406 [TBL] [Abstract][Full Text] [Related]
11. Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy. Tojo K; Tsuchiya-Suzuki A; Sekijima Y; Morita H; Sumita N; Ikeda S Amyloid; 2010 Mar; 17(1):32-5. PubMed ID: 20132088 [TBL] [Abstract][Full Text] [Related]
12. Family dynamics in transthyretin-related familial amyloid polyneuropathy Val30Met: Does genetic risk affect family functioning? Lopes A; Rodrigues C; Fonseca I; Sousa A; Branco M; Coelho T; Sequeiros J; Freitas P Clin Genet; 2018 Nov; 94(5):401-408. PubMed ID: 30019395 [TBL] [Abstract][Full Text] [Related]
13. Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases. Beirão JM; Malheiro J; Lemos C; Beirão I; Costa P; Torres P Amyloid; 2015; 22(2):117-22. PubMed ID: 26096568 [TBL] [Abstract][Full Text] [Related]
14. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan. Ueda M; Yamashita T; Misumi Y; Masuda T; Ando Y Amyloid; 2018 Sep; 25(3):143-147. PubMed ID: 30486687 [TBL] [Abstract][Full Text] [Related]
15. Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area. Cortese A; Vita G; Luigetti M; Russo M; Bisogni G; Sabatelli M; Manganelli F; Santoro L; Cavallaro T; Fabrizi GM; Schenone A; Grandis M; Gemelli C; Mauro A; Pradotto LG; Gentile L; Stancanelli C; Lozza A; Perlini S; Piscosquito G; Calabrese D; Mazzeo A; Obici L; Pareyson D J Neurol; 2016 May; 263(5):916-924. PubMed ID: 26984605 [TBL] [Abstract][Full Text] [Related]
16. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey. Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058 [TBL] [Abstract][Full Text] [Related]
17. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy. Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674 [TBL] [Abstract][Full Text] [Related]